DK131295B - Steroids of the estrane or 19-norpregnan series for use as contraceptives. - Google Patents
Steroids of the estrane or 19-norpregnan series for use as contraceptives.Info
- Publication number
- DK131295B DK131295B DK483769AA DK483769A DK131295B DK 131295 B DK131295 B DK 131295B DK 483769A A DK483769A A DK 483769AA DK 483769 A DK483769 A DK 483769A DK 131295 B DK131295 B DK 131295B
- Authority
- DK
- Denmark
- Prior art keywords
- norpregnan
- estrane
- contraceptives
- steroids
- series
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB23066/67A GB1202521A (en) | 1966-07-29 | 1966-07-29 | 01beta-CHLORO-19-NOR-STEROIDS |
GB3427566 | 1966-07-29 | ||
DK389767AA DK129004B (en) | 1966-07-29 | 1967-07-28 | Analogous process for the preparation of 9α-unsubstituted 11β-chloro-19-norsteroids of the estrane or 19-norpregane series. |
Publications (2)
Publication Number | Publication Date |
---|---|
DK131295B true DK131295B (en) | 1975-06-23 |
DK131295C DK131295C (en) | 1975-11-17 |
Family
ID=26256295
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK389767AA DK129004B (en) | 1966-07-29 | 1967-07-28 | Analogous process for the preparation of 9α-unsubstituted 11β-chloro-19-norsteroids of the estrane or 19-norpregane series. |
DK483769AA DK131295B (en) | 1966-07-29 | 1969-09-10 | Steroids of the estrane or 19-norpregnan series for use as contraceptives. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK389767AA DK129004B (en) | 1966-07-29 | 1967-07-28 | Analogous process for the preparation of 9α-unsubstituted 11β-chloro-19-norsteroids of the estrane or 19-norpregane series. |
Country Status (12)
Country | Link |
---|---|
JP (2) | JPS5021469B1 (en) |
AT (2) | AT301766B (en) |
BE (1) | BE702023A (en) |
CH (2) | CH580644A5 (en) |
DE (1) | DE1668124B2 (en) |
DK (2) | DK129004B (en) |
FR (2) | FR1565340A (en) |
GB (1) | GB1202521A (en) |
IL (1) | IL28411A (en) |
NL (1) | NL6710459A (en) |
PL (1) | PL79253B1 (en) |
SE (2) | SE349025B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1289521A (en) * | 1969-01-23 | 1972-09-20 | ||
GB1313659A (en) * | 1969-07-25 | 1973-04-18 | Glaxo Lab Ltd | 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds |
JPS5090184A (en) * | 1973-12-14 | 1975-07-19 | ||
JPS5090183A (en) * | 1973-12-14 | 1975-07-19 |
-
1966
- 1966-07-29 GB GB23066/67A patent/GB1202521A/en not_active Expired
-
1967
- 1967-07-27 PL PL1967121900A patent/PL79253B1/pl unknown
- 1967-07-28 DE DE1967G0050758 patent/DE1668124B2/en active Granted
- 1967-07-28 AT AT706867A patent/AT301766B/en not_active IP Right Cessation
- 1967-07-28 FR FR1565340D patent/FR1565340A/fr not_active Expired
- 1967-07-28 IL IL28411A patent/IL28411A/en unknown
- 1967-07-28 CH CH1075067A patent/CH580644A5/xx not_active IP Right Cessation
- 1967-07-28 DK DK389767AA patent/DK129004B/en unknown
- 1967-07-28 NL NL6710459A patent/NL6710459A/xx unknown
- 1967-07-28 BE BE702023D patent/BE702023A/xx unknown
- 1967-07-28 AT AT851569A patent/AT311564B/en not_active IP Right Cessation
- 1967-07-28 SE SE10939/67*A patent/SE349025B/xx unknown
- 1967-07-28 JP JP42048203A patent/JPS5021469B1/ja active Pending
- 1967-08-23 FR FR125405A patent/FR7812M/fr not_active Expired
-
1969
- 1969-09-10 DK DK483769AA patent/DK131295B/en unknown
-
1970
- 1970-05-19 SE SE06851/70A patent/SE350488B/xx unknown
- 1970-08-31 JP JP45075642A patent/JPS5224013B1/ja active Pending
-
1975
- 1975-08-15 CH CH1075067A patent/CH584724A5/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PL79253B1 (en) | 1975-06-30 |
GB1202521A (en) | 1970-08-19 |
SE350488B (en) | 1972-10-30 |
JPS5224013B1 (en) | 1977-06-28 |
DE1668124B2 (en) | 1976-10-07 |
DK131295C (en) | 1975-11-17 |
DE1668124A1 (en) | 1971-05-06 |
CH584724A5 (en) | 1977-02-15 |
SE349025B (en) | 1972-09-18 |
DK129004B (en) | 1974-08-05 |
NL6710459A (en) | 1968-01-30 |
IL28411A (en) | 1972-07-26 |
FR7812M (en) | 1970-05-20 |
CH580644A5 (en) | 1976-10-15 |
JPS5021469B1 (en) | 1975-07-23 |
BE702023A (en) | 1968-01-29 |
AT311564B (en) | 1973-11-26 |
AT301766B (en) | 1972-09-25 |
FR1565340A (en) | 1969-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK117896B (en) | Analogous process for the preparation of 17-esters of 21-deoxyprednisolone. | |
DK119557B (en) | Analogous process for the preparation of 17α-benzoyloxy-9α-fluoro-16β-methyl-Δ <1,4> -pregnadiene-11β, 21-diol-3,20-dione. | |
DK131295B (en) | Steroids of the estrane or 19-norpregnan series for use as contraceptives. | |
DK115547B (en) | Process for the preparation of 17α-acyloxy-16-methyl-9α-fluor-Δ <1,4> -pregnadiene-3,20-diones. | |
DK120540B (en) | Process for the preparation of 17α-alkynyl-17β-acyloxysteroids of the androstane or estrane series. | |
DK123234B (en) | Process for the preparation of desA steroids. | |
DK114060B (en) | Process for the preparation of therapeutically effective 1,2β-methylene steroids of the androstane or 9-norandrostane series. | |
DK122275B (en) | Process for the preparation of 17α-ethynyl-17β-hydroxysteroids from the androstane or oestrane series. | |
DK117420B (en) | Analogous process for the preparation of 12-oxygenated-Δ <3> -A-norandrostene-2,17-dione. | |
FR1996M (en) | Steroids of the estrane series. | |
DK122071B (en) | Analogous process for the preparation of methylenebutyrylphenols. | |
DK132226C (en) | PROCEDURE FOR THE PREPARATION OF 16ALFA, 17ALFA DIALKYL STEROIDS FROM THE PREGNAN RANGE | |
DK121372B (en) | Analogous process for the preparation of 17β- (1-alkoxycycloalkyloxy) -2α, 3α-epithio-5α-androstanes. | |
DK124126B (en) | 1,2α-Methylene-Δ <4,6> -pregnadien-17α-ol-3,20-dione derivatives for use as contraceptives. | |
DK118461B (en) | Process for the preparation of 6-halogen- or -alkyl-substituted 4-chloro-4 <4,6> -steroid dienes of the androstane or pregnane series. | |
DK129705B (en) | 16α-alkyl-3,20-diketo-Δ <4> - or -Δ <4,6> steroids of the pregnane or 19-norpregane series for use as contraceptives. | |
DK125420B (en) | Steroids of the androstane or oestrane series containing a 17α-alka-1 ', 3'-diynyl group for use as contraceptives. | |
DK123407B (en) | Steroids for use as contraceptives. | |
DK117562B (en) | Process for the preparation of 19-nor-Δ <4> -3-keto steroids. | |
DK133508B (en) | 17alpha-propadienyl steroids for use as contraceptives. | |
DK124610B (en) | Analogous process for the preparation of 4,6-dichloro-Δ <4,6> -steroids of the pregnane series. | |
DK121297B (en) | Process for the preparation of 19-hydroxyandrost-4-ene-3,17-dione. | |
DK123866B (en) | Process for the preparation of 17-ethylidene steroids or 17-ethylidene-desA-steroids. | |
DK118814B (en) | Process for the preparation of tetracycline. | |
DK116869B (en) | Process for the preparation of 6-methyl-16-fluoromethylene-4-pregnene-3,20-dione derivatives. |